82 related articles for article (PubMed ID: 12419090)
1. Production of prostaglandin e(2) by iridial melanocytes exposed to latanoprost acid, a prostaglandin F(2 alpha) analogue.
Bergh K; Wentzel P; Stjernschantz J
J Ocul Pharmacol Ther; 2002 Oct; 18(5):391-400. PubMed ID: 12419090
[TBL] [Abstract][Full Text] [Related]
2. Increased pigmentation of iridial melanocytes in primates induced by a prostaglandin analogue.
Lindquist NG; Larsson BS; Stjernschantz J
Exp Eye Res; 1999 Oct; 69(4):431-6. PubMed ID: 10504276
[TBL] [Abstract][Full Text] [Related]
3. Latanoprost-induced increase of tyrosinase transcription in iridial melanocytes.
Stjernschantz J; Ocklind A; Wentzel P; Lake S; Hu DN
Acta Ophthalmol Scand; 2000 Dec; 78(6):618-22. PubMed ID: 11167218
[TBL] [Abstract][Full Text] [Related]
4. Latanoprost-induced pigmentation in human iridial melanocytes is fibroblast dependent.
Smith-Thomas L; Moustafa M; Spada CS; Shi L; Dawson RA; Wagner M; Balafa C; Kedzie KM; Reagan JW; Krauss AH; Woodward DF; MacNeil S
Exp Eye Res; 2004 May; 78(5):973-85. PubMed ID: 15051478
[TBL] [Abstract][Full Text] [Related]
5. Short-time application of latanoprost does not stimulate melanogenesis in bovine ocular melanin-containing cells in vitro.
Loeffler KU; Sahm M; Spitznas M
Ophthalmic Res; 2001; 33(2):102-6. PubMed ID: 11244356
[TBL] [Abstract][Full Text] [Related]
6. Latanoprost and pigmentation.
Grierson I; Jonsson M; Cracknell K
Jpn J Ophthalmol; 2004; 48(6):602-12. PubMed ID: 15592791
[TBL] [Abstract][Full Text] [Related]
7. Latanoprost stimulates eumelanogenesis in iridial melanocytes of cynomolgus monkeys.
Prota G; Vincensi MR; Napolitano A; Selen G; Stjernschantz J
Pigment Cell Res; 2000 Jun; 13(3):147-50. PubMed ID: 10885672
[TBL] [Abstract][Full Text] [Related]
8. Transcription of prostanoid receptor genes and cyclooxygenase enzyme genes in cultivated human iridial melanocytes from eyes of different colours.
Wentzel P; Bergh K; Wallin O; Niemelä P; Stjernschantz J
Pigment Cell Res; 2003 Feb; 16(1):43-9. PubMed ID: 12519124
[TBL] [Abstract][Full Text] [Related]
9. Comparison between isopropyl unoprostone and latanoprost by prostaglandin E(2)induction, affinity to prostaglandin transporter, and intraocular metabolism.
Kashiwagi K; Kanai N; Tsuchida T; Suzuki M; Iizuka Y; Tanaka Y; Tsukahara S
Exp Eye Res; 2002 Jan; 74(1):41-9. PubMed ID: 11878817
[TBL] [Abstract][Full Text] [Related]
10. alpha-Methyl-p-tyrosine inhibits latanoprost-induced melanogenesis in vitro.
Drago F; Marino A; La Manna C
Exp Eye Res; 1999 Jan; 68(1):85-90. PubMed ID: 9986745
[TBL] [Abstract][Full Text] [Related]
11. Prostaglandin-induced iridial pigmentation in primates.
Selén G; Stjernschantz J; Resul B
Surv Ophthalmol; 1997 Feb; 41 Suppl 2():S125-8. PubMed ID: 9154288
[TBL] [Abstract][Full Text] [Related]
12. Incidence and severity of iris pigmentation on latanoprost-treated glaucoma eyes.
Chou SY; Chou CK; Kuang TM; Hsu WM
Eye (Lond); 2005 Jul; 19(7):784-7. PubMed ID: 15359238
[TBL] [Abstract][Full Text] [Related]
13. Mechanism and clinical significance of prostaglandin-induced iris pigmentation.
Stjernschantz JW; Albert DM; Hu DN; Drago F; Wistrand PJ
Surv Ophthalmol; 2002 Aug; 47 Suppl 1():S162-75. PubMed ID: 12204714
[TBL] [Abstract][Full Text] [Related]
14. Effects of isopropyl unoprostone and latanoprost on melanogenesis in mouse epidermal melanocytes.
Kashiwagi K; Tsukamoto K; Suzuki M; Tsukahara S
J Glaucoma; 2002 Feb; 11(1):57-64. PubMed ID: 11821691
[TBL] [Abstract][Full Text] [Related]
15. The color of the human eye: a review of morphologic correlates and of some conditions that affect iridial pigmentation.
Imesch PD; Wallow IH; Albert DM
Surv Ophthalmol; 1997 Feb; 41 Suppl 2():S117-23. PubMed ID: 9154287
[TBL] [Abstract][Full Text] [Related]
16. The incidence and time-course of latanoprost-induced iridial pigmentation as a function of eye color.
Wistrand PJ; Stjernschantz J; Olsson K
Surv Ophthalmol; 1997 Feb; 41 Suppl 2():S129-38. PubMed ID: 9154289
[TBL] [Abstract][Full Text] [Related]
17. Iridial pigmentation induced by latanoprost ophthalmic solution in Japanese glaucoma patients.
Chiba T; Kashiwagi K; Kogure S; Abe K; Shibuya T; Furuichi M; Iijima H; Tsukahara S
J Glaucoma; 2001 Oct; 10(5):406-10. PubMed ID: 11711839
[TBL] [Abstract][Full Text] [Related]
18. Morphometric effects of long-term exposure to latanoprost.
Cracknell KP; Grierson I; Hogg P
Ophthalmology; 2007 May; 114(5):938-48. PubMed ID: 17292473
[TBL] [Abstract][Full Text] [Related]
19. A study of iridectomy histopathologic features of latanoprost- and non-latanoprost-treated patients.
Albert DM; Gangnon RE; Zimbric ML; Damico CM; Fisher MR; Gleiser J; Grossniklaus HE; Green WR
Arch Ophthalmol; 2004 Nov; 122(11):1680-5. PubMed ID: 15534130
[TBL] [Abstract][Full Text] [Related]
20. Fine structural evaluation of the iris after unilateral treatment with latanoprost in patients undergoing bilateral trabeculectomy (the Mainz II study).
Pfeiffer N; Grierson I; Goldsmith H; Appleton P; Hochgesand D; Winkgen A
Arch Ophthalmol; 2003 Jan; 121(1):23-31. PubMed ID: 12523881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
